Literature DB >> 19625481

Algorithm combining toxin immunoassay and stool culture for diagnosis of Clostridium difficile infection.

Bo-Moon Shin1, Eun Young Kuak, Eun Joo Lee, J Glenn Songer.   

Abstract

Enzyme immunoassays (EIA) to detect glutamate dehydrogenase or toxins A (TcdA) and B (TcdB), a cytotoxicity assay, and bacteriologic culture have disadvantages when applied individually to diagnosis of Clostridium difficile infections. Stool specimens (n = 1,596) were subjected to toxin detection via an enzyme-linked fluorescent immunoassay (ELFA; Vidas CDAB assay) and bacteriologic culture for toxigenic C. difficile in a three-step algorithm with additional toxigenic culture. Isolates (n = 163) from ELFA-negative stool specimens were examined via ELFA for toxin production. We amplified tcdA and tcdB from C. difficile isolates and tcdB from stool specimens that were ELFA positive or equivocal and culture negative, and we compared the results to those obtained with the three-step algorithm. More than 26% of stool specimens (419/1,596) were culture positive, yielding 248 isolates (59.2%) with both toxin genes (tcdA- and tcdB-positive isolates), 88 isolates (21.0%) with either tcdA or tcdB, and 83 (19.8%) that had no toxin genes (tcdA- and tcdB-negative isolates). Among 49 (culture-negative/ELFA-positive or -equivocal) stool specimens, 53.1% (26/49) represented tcdB-positive isolates. Therefore, the total number of PCR-positive cases was 362, and 27.1% (98/362) of these were detected through toxigenic culture. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 63.3%, 96.7%, 90.5%, and 92.4% (ELFA alone); 92.8%, 93.3%, 80.2%, and 97.8% (culture); and 70.7%, 91.4%, 95.5%, and 100% (three-step algorithm ELFA and bacterial culture with toxigenic culture), respectively, with culture and PCR for tcdA and tcdB as the standards. Thus, sensitivity and specificity were highest using culture and ELFA, respectively, but we recommend the three-step algorithm comprising EIA to detect both toxins and toxigenic culture for C. difficile as a practical method for achieving better PPV and NPV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625481      PMCID: PMC2738110          DOI: 10.1128/JCM.00609-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Nosocomial outbreak of Clostridium difficile-associated diarrhoea due to a clindamycin-resistant enterotoxin A-negative strain.

Authors:  E J Kuijper; J de Weerdt; H Kato; N Kato; A P van Dam; E R van der Vorm; J Weel; C van Rheenen; J Dankert
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-08       Impact factor: 3.267

2.  High prevalence of toxin A-negative toxin B-positive Clostridium difficile in hospitalized patients with gastrointestinal disease.

Authors:  Zmira Samra; Smadar Talmor; Judi Bahar
Journal:  Diagn Microbiol Infect Dis       Date:  2002-07       Impact factor: 2.803

3.  Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains.

Authors:  A Lozniewski; C Rabaud; E Dotto; M Weber; F Mory
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Evaluation of a test for Clostridium difficile toxins A and B for the diagnosis of neonatal swine enteritis.

Authors:  Karen W Post; B Helen Jost; J Glenn Songer
Journal:  J Vet Diagn Invest       Date:  2002-05       Impact factor: 1.279

5.  Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France.

Authors:  Frédéric Barbut; Valérie Lalande; Béatrice Burghoffer; Huong Vu Thien; Emmanuel Grimprel; Jean-Claude Petit
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

6.  Clonal dissemination of a toxin-A-negative/toxin-B-positive Clostridium difficile strain from patients with antibiotic-associated diarrhea in Poland.

Authors:  H Pituch; N van den Braak; W van Leeuwen; A van Belkum; G Martirosian; P Obuch-Woszczatyński; M Łuczak; F Meisel-Mikołajczyk
Journal:  Clin Microbiol Infect       Date:  2001-08       Impact factor: 8.067

7.  Fatal pseudomembranous colitis associated with a variant clostridium difficile strain not detected by toxin A immunoassay.

Authors:  S Johnson; S A Kent; K J O'Leary; M M Merrigan; S P Sambol; L R Peterson; D N Gerding
Journal:  Ann Intern Med       Date:  2001-09-18       Impact factor: 25.391

8.  Comparison of the TOX A/B test to a cell culture cytotoxicity assay for the detection of Clostridium difficile in stools.

Authors:  W E Aldeen; M Bingham; A Aiderzada; J Kucera; S Jense; K C Carroll
Journal:  Diagn Microbiol Infect Dis       Date:  2000-04       Impact factor: 2.803

9.  Six rapid tests for direct detection of Clostridium difficile and its toxins in fecal samples compared with the fibroblast cytotoxicity assay.

Authors:  David K Turgeon; Thomas J Novicki; John Quick; LaDonna Carlson; Pat Miller; Bruce Ulness; Anne Cent; Rhoda Ashley; Ann Larson; Marie Coyle; Ajit P Limaye; Brad T Cookson; Thomas R Fritsche
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

10.  Multicentre study of the prevalence of toxigenic Clostridium difficile in Korea: results of a retrospective study 2000-2005.

Authors:  Bo-Moon Shin; Eun Young Kuak; Hyeon Mi Yoo; Eui Chong Kim; Kyungwon Lee; Jung-Oak Kang; Dong Hee Whang; Jeong-Hwan Shin
Journal:  J Med Microbiol       Date:  2008-06       Impact factor: 2.472

View more
  18 in total

1.  Assessment of Clostridium difficile infections by quantitative detection of tcdB toxin by use of a real-time cell analysis system.

Authors:  Alex B Ryder; Ying Huang; Haijing Li; Min Zheng; Xiaobo Wang; Charles W Stratton; Xiao Xu; Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2010-08-18       Impact factor: 5.948

2.  Clostridioides difficile laboratory diagnostic techniques: a comparative approach of rapid and molecular methods.

Authors:  Thais Simões Camargo; Moacyr Silva Junior; Luis Fernando Aranha Camargo; Veronica Pivetta Biotto; André Mario Doi; Paula Celia Mariko Koga; Carolina Nunes França; Marines Dalla Valle Martino
Journal:  Arch Microbiol       Date:  2021-01-18       Impact factor: 2.552

3.  Comparison of BD GeneOhm Cdiff and Seegene Seeplex ACE PCR assays using toxigenic Clostridium difficile culture for direct detection of tcdB from stool specimens.

Authors:  Bo-Moon Shin; Se Jin Mun; Soo Jin Yoo; Eun Young Kuak
Journal:  J Clin Microbiol       Date:  2012-09-05       Impact factor: 5.948

Review 4.  Laboratory Tests for the Diagnosis of Clostridium difficile.

Authors:  Karen C Carroll; Masako Mizusawa
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

5.  Clostridium Difficile Colitis in Trauma Patients - a Global Step by Step Review.

Authors:  Silviu Morteanu; Georgiana Chirt; Mircea Beuran
Journal:  Maedica (Buchar)       Date:  2015-06

6.  Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.

Authors:  Bobby L Boyanton; Preethi Sural; Caroline R Loomis; Christine Pesta; Laura Gonzalez-Krellwitz; Barbara Robinson-Dunn; Paul Riska
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

7.  Evaluation of a chromogenic culture medium for isolation of Clostridium difficile within 24 hours.

Authors:  John D Perry; Kerry Asir; Diane Halimi; Sylvain Orenga; Joanne Dale; Michelle Payne; Ruth Carlton; Jim Evans; F Kate Gould
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

Review 8.  The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge.

Authors:  E R Dubberke; D B Haslam; C Lanzas; L D Bobo; C-A D Burnham; Y T Gröhn; P I Tarr
Journal:  Zoonoses Public Health       Date:  2010-09-24       Impact factor: 2.702

9.  What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection?

Authors:  Mark H Wilcox; Tim Planche; Ferric C Fang; Peter Gilligan
Journal:  J Clin Microbiol       Date:  2010-10-27       Impact factor: 5.948

10.  Comparison of ImmunoCard Toxins A&B and the new semiautomated Vidas Clostridium difficile Toxin A&B tests for diagnosis of C. difficile infection.

Authors:  Luis Alcalá; Mercedes Marín; María Madrid; Esther Domínguez-García; Pilar Catalán; María Teresa Peláez; Mar Sánchez-Somolinos; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.